EcoDrugPlus

Endothelin Converting Enzyme 1

Ensembl ID : ENSCLAG00000012254
Gene Symbol: ECE1
2 Cross references
230 Possible Orthologues:

Endothelin Receptor Type A

Ensembl ID : ENSCLAG00000005819
Gene Symbol: EDNRA
3 Cross references
269 Possible Orthologues:

Endothelin Receptor Type B

Ensembl ID : ENSCLAG00000003613
Gene Symbol: EDNRB
3 Cross references
267 Possible Orthologues:

Enhancer Of Zeste 2 Polycomb Repressive Complex 2 Subunit

Ensembl ID : ENSCLAG00000001762
Gene Symbol: EZH2
3 Cross references
236 Possible Orthologues:

Epidermal Growth Factor Receptor

Ensembl ID : ENSCLAG00000007797
Gene Symbol: EGFR
2 Cross references
286 Possible Orthologues:

Epoxide Hydrolase 2

Ensembl ID : ENSCLAG00000014569
Gene Symbol: EPHX2
2 Cross references
204 Possible Orthologues:

Erb-B2 Receptor Tyrosine Kinase 2

Ensembl ID : ENSCLAG00000015834
Gene Symbol: ERBB2
2 Cross references
200 Possible Orthologues:

Erb-B2 Receptor Tyrosine Kinase 3

Ensembl ID : ENSCLAG00000010219
Gene Symbol: ERBB3
2 Cross references
280 Possible Orthologues:

Erb-B2 Receptor Tyrosine Kinase 4

Ensembl ID : ENSCLAG00000006948
Gene Symbol: ERBB4
2 Cross references
320 Possible Orthologues:

Estrogen Receptor 1

Ensembl ID : ENSCLAG00000003026
Gene Symbol: ESR1
2 Cross references
212 Possible Orthologues:

Estrogen Receptor 2

Ensembl ID : ENSCLAG00000005080
Gene Symbol: ESR2
2 Cross references
274 Possible Orthologues:

Estrogen Related Receptor Gamma

Ensembl ID : ENSCLAG00000006694
Gene Symbol: ESRRG
2 Cross references
206 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).